Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

Arvind Dasari, Cathy Eng, Alberto Sobrero et al.|The Lancet|2023

Cited by 319